Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation
NCT03143894 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2021-05-12
Summary
This study will test the preliminary efficacy of transcranial direct current stimulation (tDCS) to improve fatigue and cognition in women with a history of breast cancer and persistent fatigue.
Conditions
- Breast Cancer
- Cognitive Dysfunction
- Fatigue
Interventions
- DEVICE
-
tDCS
Transcranial direct current stimulation (tDCS) is a safe, portable, non-invasive form TDCS is a form of non-invasive electrical brain stimulation using low amplitude direct current to facilitate neuronal transmission beneath scalp electrodes.
- OTHER
-
Sham tDCS
Sham Transcranial direct current stimulation (tDCS)..
Sponsors & Collaborators
-
Under Armour, Inc.
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Tracy D Vannorsdall, PhD · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-04-21
- Primary Completion
- 2020-06-24
- Completion
- 2020-06-24
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study
NCT02385656 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Ketamine on Fatigue Following Cancer Therapy
NCT02317341 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Transdermal Methylphenidate for Cancer-Related Fatigue
NCT01124500 ·Status: WITHDRAWN ·Phase: NA
-
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
NCT02592447 ·Status: COMPLETED ·Phase: NA
-
Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer
NCT01330446 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Developmental Study on Fatigue in Cancer
NCT00034450 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
NCT00042848 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
NCT00516269 ·Status: TERMINATED ·Phase: PHASE3
-
Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)
NCT00917748 ·Status: COMPLETED ·Phase: PHASE3
-
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
NCT05123001 ·Status: COMPLETED
-
Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy
NCT00379665 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil in Treating Fatigue in Patients With Cancer
NCT00112515 ·Status: UNKNOWN ·Phase: NA
-
Modafinil to Improve Fatiguability
NCT05333250 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
NCT04290897 ·Status: COMPLETED ·Phase: PHASE2
-
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
NCT03035409 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot
NCT01007695 ·Status: TERMINATED ·Phase: PHASE1
-
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo
NCT00775645 ·Status: COMPLETED ·Phase: PHASE3
-
Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy
NCT02332928 ·Status: TERMINATED ·Phase: PHASE3
-
Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer
NCT02521077 ·Status: WITHDRAWN ·Phase: PHASE2
-
Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors
NCT02452710 ·Status: TERMINATED ·Phase: NA
-
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
NCT01191216 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Methylphenidate on Cancer-related Cognitive Impairment
NCT02970500 ·Status: TERMINATED ·Phase: PHASE2
-
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate
NCT02361125 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue
NCT00792077 ·Status: COMPLETED ·Phase: PHASE2
-
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer
NCT05251714 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2